Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia-Reference-Cited by-同舟云学术

Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia

Published:2009-07 Issue:10 Volume:45 Page:1877-1889
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

San José-Eneriz Edurne,Agirre Xabier,Jiménez-Velasco Antonio,Cordeu Lucia,Martín Vanesa,Arqueros Victor,Gárate Leire,Fresquet Vicente,Cervantes Francisco,Martínez-Climent José A.,Heiniger Anabel,Torres Antonio,Prósper Felipe,Roman-Gomez Jose

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL;Horita;J Exp Med,2000

2. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia;Bedi;Blood,1994

3. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL;Amarante-Mendes;Oncogene,1998

4. Bim: a novel member of the Bcl-2 family that promotes apoptosis;O’Connor;EMBO J,1998

5. Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds;Aichberger;Cancer Res,2005

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into existing and futuristic treatment approach for chronic myeloid leukaemia;Indian Journal of Medical Research;2024-08-03

2. Epigenetic Alterations as an Adaptive Response to Chemotherapy;Drug Resistance in Cancer: Mechanisms and Strategies;2024

3. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia;Biochemical Journal;2023-01-31

4. Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool;International Journal of Molecular Sciences;2022-12-30

5. BCL-2 protein family: attractive targets for cancer therapy;Apoptosis;2022-11-07